Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FMAUK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,714
Award facts
- Contract value 100% obligated
- $8,713.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency Medical Supply Chain procures pharmaceutical products to support the Department of Defense healthcare system, including services to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across diverse therapeutic domains, with delivery orders ranging from small transactions to substantial orders exceeding $45,000. The company's DLA prime contract establishes it as a critical vendor for specialized medications, including diabetes treatments, neurological pharmaceuticals, and other essential medical commodities required by military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FMAUK?
SPE2DB26FMAUK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FMAUK worth?
The government has obligated $8,714 on SPE2DB26FMAUK.
Is contract SPE2DB26FMAUK an order under another contract?
Yes. SPE2DB26FMAUK is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMAUK competed?
The extent of competition for SPE2DB26FMAUK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award